Patents Assigned to CYTOLYF THERAPEUTICS LLC
  • ZINC ACTIVATED THYMULIN AND METHODS OF PREPARATION AND ADMINISTRATION
    Publication number: 20210060117
    Abstract: Embodiments of the invention generally fall into the category of activated thymulin synthesis and applications thereof. Embodiments, delivered orally or parenterally, are used to treat malignancies and immune system dysfunctions by activating cytotoxic T cells, increasing the generation of T helper 1 cells and/or boosting the production of interleukin 2.
    Type: Application
    Filed: August 14, 2020
    Publication date: March 4, 2021
    Applicant: CYTOLYF THERAPEUTICS LLC
    Inventors: ANAND S. PRASAD, ROY A. VARGHESE, PHILIP C. BIRD, CHARLES CLAYTON